These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 21118149)
1. Induction of chromosome malsegregation by nanomaterials. Gonzalez L; Decordier I; Kirsch-Volders M Biochem Soc Trans; 2010 Dec; 38(6):1691-7. PubMed ID: 21118149 [TBL] [Abstract][Full Text] [Related]
2. Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes. Tavares AM; Louro H; Antunes S; Quarré S; Simar S; De Temmerman PJ; Verleysen E; Mast J; Jensen KA; Norppa H; Nesslany F; Silva MJ Toxicol In Vitro; 2014 Feb; 28(1):60-9. PubMed ID: 23811260 [TBL] [Abstract][Full Text] [Related]
3. A high throughput in vitro analytical approach to screen for oxidative stress potential exerted by nanomaterials using a biologically relevant matrix: human blood serum. Rogers EJ; Hsieh SF; Organti N; Schmidt D; Bello D Toxicol In Vitro; 2008 Sep; 22(6):1639-47. PubMed ID: 18593597 [TBL] [Abstract][Full Text] [Related]
4. Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. Gonzalez L; Sanderson BJ; Kirsch-Volders M Mutagenesis; 2011 Jan; 26(1):185-91. PubMed ID: 21164201 [TBL] [Abstract][Full Text] [Related]
7. Development of an in vitro screening method for safety evaluation of nanomaterials. Matsuoka A; Onfelt A; Matsuda Y; Nakaoka R; Haishima Y; Yudasaka M; Iijima S; Tsuchiya T Biomed Mater Eng; 2009; 19(1):19-27. PubMed ID: 19458442 [TBL] [Abstract][Full Text] [Related]
9. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies]. Hirose A; Nishimura T; Kanno J Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702 [TBL] [Abstract][Full Text] [Related]
10. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines. Warheit DB; Donner EM Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448 [TBL] [Abstract][Full Text] [Related]
11. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications. Johnston H; Brown D; Kermanizadeh A; Gubbins E; Stone V J Control Release; 2012 Dec; 164(3):307-13. PubMed ID: 22940205 [TBL] [Abstract][Full Text] [Related]
12. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Balasubramanyam A; Sailaja N; Mahboob M; Rahman MF; Hussain SM; Grover P Mutagenesis; 2009 May; 24(3):245-51. PubMed ID: 19237533 [TBL] [Abstract][Full Text] [Related]
13. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Murdock RC; Braydich-Stolle L; Schrand AM; Schlager JJ; Hussain SM Toxicol Sci; 2008 Feb; 101(2):239-53. PubMed ID: 17872897 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of EB1 effects on microtubule dynamics. Coquelle FM; Vitre B; Arnal I Biochem Soc Trans; 2009 Oct; 37(Pt 5):997-1001. PubMed ID: 19754439 [TBL] [Abstract][Full Text] [Related]
15. Biomonitoring of genotoxic effects for human exposure to nanomaterials: The challenge ahead. Gonzalez L; Kirsch-Volders M Mutat Res Rev Mutat Res; 2016; 768():14-26. PubMed ID: 27234560 [TBL] [Abstract][Full Text] [Related]
16. Identification of tubulin drug binding sites and prediction of relative differences in binding affinities to tubulin isotypes using digital signal processing. Chen K; Huzil JT; Freedman H; Ramachandran P; Antoniou A; Tuszynski JA; Kurgan L J Mol Graph Model; 2008 Nov; 27(4):497-505. PubMed ID: 18951052 [TBL] [Abstract][Full Text] [Related]
17. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. Landsiedel R; Ma-Hock L; Haussmann HJ; van Ravenzwaay B; Kayser M; Wiench K Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):399-413. PubMed ID: 22639437 [TBL] [Abstract][Full Text] [Related]
18. Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity. Wang A; Marinakos SM; Badireddy AR; Powers CM; Houck KA Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):430-48. PubMed ID: 23661551 [TBL] [Abstract][Full Text] [Related]
19. Nanotoxicity: a growing need for study in the endocrine system. Lu X; Liu Y; Kong X; Lobie PE; Chen C; Zhu T Small; 2013 May; 9(9-10):1654-71. PubMed ID: 23401134 [TBL] [Abstract][Full Text] [Related]
20. Nanomaterial translocation--the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review. Kermanizadeh A; Balharry D; Wallin H; Loft S; Møller P Crit Rev Toxicol; 2015; 45(10):837-72. PubMed ID: 26140391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]